Pharmacy Benefit Managers – Thrilled to see the DRUG Act introduced
As someone who is a frequent visitor at the pharmacy counter, I am keenly aware of issues that burden patients, especially the issue of pharmacy benefit managers.
As someone who is a frequent visitor at the pharmacy counter, I am keenly aware of issues that burden patients, especially the issue of pharmacy benefit managers.
When the Centers for Medicare and Medicaid Services (CMS) changes billing codes from one year to the next, the effects often don’t typically warrant major outcries.
People experiencing a near-death event often talk about having their life flash before them in ultra-fast-fast forward, now I know what they mean.
As people get older, their reliance on prescription drugs invariably increase.
First lady Jill Biden on Wednesday welcomed a new proposal to have Medicare pay for navigation services for cancer patients, saying it will make “an enormous difference in people's lives.”
The United States is in the midst of some of the worst cancer drug shortages in history, affecting thousands of patients across the country who face delayed or cancelled chemotherapy appointments. But these shortages aren’t just bad for current patients, experts say; their effects on cancer research may be felt for years to come.
A recent update to the US recommendations for breast cancer screening is raising concerns about the costs associated with potential follow-up tests, while also renewing debates about the timing of these tests and the screening approaches used.
Researchers from the Perelman School of Medicine at the University of Pennsylvania and Children’s Hospital of Philadelphia (CHOP) found that cancer patients who continued to smoke after their diagnosis were significantly more likely to receive treatment for tobacco use when “nudges” to provide tobacco treatment were directed at clinicians through the electronic health record.
Julie Eaton's road to recovery from breast cancer had been progressing well after four rounds of chemotherapy this spring and summer.
GenesisCare, an international cancer treatment company backed by the private equity firms KKR and China Resources Group, recently filed for bankruptcy under Chapter 11, with reorganization plans to sell its 130 U.S.-based practices.